U.S. Skeptical About Permanent Safe Harbor for GLOBE Tax Framework
Posted on
What Will It Take to Get Big Pharma Profits Into the United States?
Martin A. Sullivan examines Form 10-K data from multinational pharmaceutical companies indicating that recent tax policy changes haven’t induced them to shift profits back to the United States, and he explores why that is a different story for tech companies.
To read more go here Subscription Required
Member Companies
